Evidence map›Paper›PMID 37304434›Full record

ArticleFrontiers in psychiatry2023

A single case report of STN-DBS for severe crack-cocaine dependence: double-blind ON vs. SHAM randomized controlled assessment.

Florence Vorspan, Philippe Domenech, David Grabli, Jérôme Yelnik, Marine Delavest, Charles Dauré, Frank Bellivier, Antoine Pelissolo, Hayat Belaid, Christelle Baunez and 2 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Zona incerta: from Parkinson's disease to addiction.Frontiers in neural circuits · 2025
    Article
  7. Article
  8. Deep brain stimulation for psychostimulant use disorders.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Florence Vorspan *Université de Paris Cité, INSERM UMRS 1144, Paris, Île-de-France, France.
Philippe Domenech *Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France.
David GrabliSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France.
Jérôme YelnikSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France.
Marine DelavestAssistance Publique - Hôpitaux de Paris, GHU NORD, GH Lariboisière-Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Paris, Île-de-France, France.
Charles DauréUniversité de Paris Cité, INSERM UMRS 1144, Paris, Île-de-France, France.
Frank BellivierUniversité de Paris Cité, INSERM UMRS 1144, Paris, Île-de-France, France.
Antoine PelissoloAssistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor - Albert Chenevier, DMU IMPACT, Département Médical-Universitaire de Psychiatrie et d'Addictologie, Créteil, France.
Hayat BelaidAssistance Publique - Hôpitaux de Paris, GHU Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Neurochirurgie, Paris, Île-de-France, France.
Christelle BaunezUMR7289 CNRS & Aix-Marseille Université, Marseille, Provence-Alpes-Côôte-d'Azur, France.
Carine KarachiSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France.
Luc MalletSorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crack-cocaine dependence is a severe condition with a high mortality rate. This single case study report details the first deep brain stimulation (DBS) trial targeting the sub-thalamic nucleus (STN) for crack-cocaine dependence. The investigation aimed to assess the effects of STN-DBS on cocaine craving and cocaine use, as well as STN-DBS safety and tolerance in this indication. In this pilot study, we performed double blind cross-over trials, with "ON-DBS" vs. "SHAM-DBS" for 1-month periods. STN-DBS failed to reduce cocaine craving and use. An episode of DBS-induced hypomania occurred after several weeks of cocaine intake at stimulation parameters previously well tolerated. Future research on cocaine dependence should be conducted after a prolonged abstinence period and/or explore novel types of stimulation patterns.

Indexed as

cocaine dependencecontrolled clinical trialcrack-cocainedeep brain stimulationsubthalamic nucleus

Identifiers

PMID37304434
PMCPMC10248431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.